Winton Capital »

Peregrine Pharmaceuticals shares owned by Winton Capital

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Winton Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $106k 16k 6.50
2023-09-30 $367k 39k 9.44
2023-06-30 $249k 18k 13.97
2021-09-30 $442k 21k 21.56
2021-06-30 $515k 20k 25.66
2021-03-31 $283k 16k 18.24
2019-12-31 $367k 48k 7.68
2019-09-30 $377k 71k 5.31